Rare diseases
Investigational molecules
Locations
172 conditions with trials, the busiest first
481 trials across Europe, recruiting first
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DNL952 in Adults with Late‑Onset Pompe Disease
GermanyBisoprolol in Patients After Myocardial Infarction with Preserved Ejection Fraction During Cardiac Rehabilitation
BelgiumStudy to evaluate if colchicine reduces inflammation in patients with chronic coronary artery disease
DenmarkA study to compare continuous infusion and intermittent injections of furosemide and amiloride hydrochloride in patients hospitalized with acute heart failure and fluid overload
DenmarkA study to compare the effects of BI 690517 and spironolactone on kidney function in patients with heart failure, cardiovascular disease, or chronic kidney disease
The NetherlandsA study to evaluate the safety and effectiveness of KPL-387 in patients with well-controlled recurrent pericarditis
FranceA study evaluating the effect of methylprednisolone compared to sodium chloride in patients with a heart attack
DenmarkA study to evaluate the effectiveness of R2R01 in preventing acute kidney injury in patients at high risk following heart surgery.
GermanyA study of tirofiban and adenosine to treat small blood vessel damage in patients with ST-elevation myocardial infarction
FranceStudy of the efficacy and safety of inclisiran and a drug combination in patients with acute coronary syndrome
FranceA Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease
BelgiumComparing hydrochlorothiazide and valsartan for treating high blood pressure in patients with hypertrophic obstructive cardiomyopathy
AustriaThe therapies tested most often in Cardiac disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
